EconPapers    
Economics at your fingertips  
 

Caffeine alters plasma adenosine levels

Lydia A. Conlay, Jeffrey A. Conant, Fred deBros and Richard Wurtman
Additional contact information
Lydia A. Conlay: Massachusetts General Hospital and Harvard Medical School
Jeffrey A. Conant: Massachusetts General Hospital and Harvard Medical School
Fred deBros: Massachusetts General Hospital and Harvard Medical School
Richard Wurtman: Laboratory of Neuroendocrine Regulation

Nature, 1997, vol. 389, issue 6647, 136-136

Abstract: Abstract Since the delights of tea were discovered by Emperor Shen Nung in 2737 BC, methylxanthines have been common in the human diet. Today, the methylxanthine caffeineis the most commonly consumed drug in the world1, with actions mediated primarily by adenosine receptor blockade2. We now report that caffeine increases plasma adenosine concentration in a manner that is dose-related, saturable, and mimicked by peripheral adenosine receptor blockade. Opposite effects are seen after caffeine withdrawal, indicative of a receptor-mediated effect.

Date: 1997
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/38160 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:389:y:1997:i:6647:d:10.1038_38160

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/38160

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:nature:v:389:y:1997:i:6647:d:10.1038_38160